X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs SUVEN LIFE - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS SUVEN LIFE J.B.CHEMICALS/
SUVEN LIFE
 
P/E (TTM) x 15.0 19.2 78.2% View Chart
P/BV x 2.4 3.6 66.6% View Chart
Dividend Yield % 0.2 1.1 15.5%  

Financials

 J.B.CHEMICALS   SUVEN LIFE
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
SUVEN LIFE
Mar-16
J.B.CHEMICALS/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs318339 94.0%   
Low Rs200144 138.2%   
Sales per share (Unadj.) Rs148.039.2 377.1%  
Earnings per share (Unadj.) Rs19.17.5 255.8%  
Cash flow per share (Unadj.) Rs23.98.8 272.9%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Dividend yield (eoy) %0.20.8 23.3%  
Book value per share (Unadj.) Rs128.949.0 263.2%  
Shares outstanding (eoy) m84.82127.28 66.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.76.2 28.4%   
Avg P/E ratio x13.632.4 41.9%  
P/CF ratio (eoy) x10.827.5 39.3%  
Price / Book Value ratio x2.04.9 40.7%  
Dividend payout %2.626.8 9.8%   
Avg Mkt Cap Rs m21,95130,732 71.4%   
No. of employees `0002.71.0 286.6%   
Total wages/salary Rs m1,841416 442.2%   
Avg. sales/employee Rs Th4,590.95,236.1 87.7%   
Avg. wages/employee Rs Th673.4436.5 154.3%   
Avg. net profit/employee Rs Th592.1995.5 59.5%   
INCOME DATA
Net Sales Rs m12,5514,995 251.3%  
Other income Rs m542194 279.9%   
Total revenues Rs m13,0935,189 252.3%   
Gross profit Rs m2,0551,233 166.7%  
Depreciation Rs m412167 246.7%   
Interest Rs m9654 176.6%   
Profit before tax Rs m2,0881,205 173.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469255 184.0%   
Profit after tax Rs m1,619950 170.4%  
Gross profit margin %16.424.7 66.3%  
Effective tax rate %22.521.2 106.1%   
Net profit margin %12.919.0 67.8%  
BALANCE SHEET DATA
Current assets Rs m7,7784,986 156.0%   
Current liabilities Rs m4,3581,042 418.1%   
Net working cap to sales %27.279.0 34.5%  
Current ratio x1.84.8 37.3%  
Inventory Days Days5561 89.6%  
Debtors Days Days8039 204.5%  
Net fixed assets Rs m5,7133,126 182.8%   
Share capital Rs m170127 133.2%   
"Free" reserves Rs m10,5473,717 283.7%   
Net worth Rs m10,9376,236 175.4%   
Long term debt Rs m0432 0.0%   
Total assets Rs m15,5748,079 192.8%  
Interest coverage x22.823.2 98.2%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.6 130.3%   
Return on assets %11.012.4 88.6%  
Return on equity %14.815.2 97.2%  
Return on capital %20.018.9 105.8%  
Exports to sales %48.787.5 55.7%   
Imports to sales %7.112.2 57.9%   
Exports (fob) Rs m6,1154,371 139.9%   
Imports (cif) Rs m889611 145.5%   
Fx inflow Rs m6,1694,666 132.2%   
Fx outflow Rs m1,285942 136.4%   
Net fx Rs m4,8843,724 131.1%   
CASH FLOW
From Operations Rs m1,397922 151.5%  
From Investments Rs m-320-619 51.7%  
From Financial Activity Rs m-1,196-698 171.2%  
Net Cashflow Rs m-102-396 25.9%  

Share Holding

Indian Promoters % 55.4 63.4 87.4%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 0.0 -  
FIIs % 3.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 36.5 101.4%  
Shareholders   30,437 37,287 81.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   FRESENIUS KABI ONCO.  DIVIS LABORATORIES  ALEMBIC LTD  ALEMBIC PHARMA  ELDER PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Global Stock Markets Chart Modest Gains(RoundUp)

Global financial markets ended the holiday shortened week with modest gains. The rally put behind days of decline as concerns regarding swift interest rates hikes were put to ease.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 23, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS